Autonomix Medical Inc
Research Autonomix Medical Inc (AMIX) on Bullrun: market cap USD 1.69M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAMIX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.69M
- Financial periodFY2026
- RevenueUSD 0
- Net income-USD 16.72M
- Free cash flow-USD 12.29M
Valuation Snapshot
latest market cap is USD 1.69M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 0 | -USD 16.72M | -USD 12.29M | n/a | -48.72 | USD 7.00M | n/a | USD 5.90M |
| FY2025 | USD 0 | -USD 11.41M | -USD 8.27M | n/a | -135.66 | USD 9.14M | n/a | USD 8.10M |
| FY2024 | USD 0 | -USD 15.43M | -USD 6.62M | n/a | -311.22 | USD 8.61M | USD 0 | USD 7.63M |
| FY2023 | USD 0 | -USD 1.99M | -USD 1.85M | n/a | -39.58 | USD 865.00K | USD 0 | USD 644.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 1.69M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.28M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.26M | n/a | n/a | n/a |
About Autonomix Medical Inc
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Autonomix Medical Inc's market cap?
Autonomix Medical Inc's market capitalization is USD 1.69M.
What does Autonomix Medical Inc do?
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc.